State Street’s Journey Medical DERM Stock Holding History

State Street’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	237,288 +63,951	+37%	+$496K	﹤0.01%	3464
2025 Q4	$1.34M	Buy	173,337 +27,300	+19%	+$214K	﹤0.01%	3460
2025 Q3	$1.04M	Buy	146,037 +31,061	+27%	+$225K	﹤0.01%	3504
2025 Q2	$826K	Buy	114,976 +86,023	+297%	+$595K	﹤0.01%	3527
2025 Q1	$171K	Hold	28,953	–	–	﹤0.01%	3864
2024 Q4	$113K	Buy	28,953 +3,400	+13%	+$18.6K	﹤0.01%	3964
2024 Q3	$144K	Hold	25,553	–	–	﹤0.01%	3897
2024 Q2	$144K	Hold	25,553	–	–	﹤0.01%	3911
2024 Q1	$94K	Hold	25,553	–	–	﹤0.01%	4038
2023 Q4	$147K	Buy	25,553 +13,700	+116%	+$61K	﹤0.01%	3959
2023 Q3	$32.5K	Buy	+11,853	New	+$26.5K	﹤0.01%	4368

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street's DERM Position: Q1 2026 in Review

State Street increased its Journey Medical (DERM) stake by 37% in Q1 2026, buying an estimated $496K and bringing the position to 237,288 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3464.

State Street first reported a position in DERM in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.34M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

State Street held 237,288 shares of Journey Medical worth $1.11M as of Q1 2026.
State Street bought 63,951 Journey Medical shares in Q1 2026, an estimated $496K.
Journey Medical made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3464 holding.
State Street first reported a position in Journey Medical in Q3 2023 and has held it in 11 quarters since.
State Street's Journey Medical position peaked at $1.34M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.